NA-ACCORD

Link to all NA-ACCORD PubMed Publications

2775998 YAE5EUBI 2025 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 255 https://www.iedea.org/wp-content/plugins/zotpress/

2775998 YAE5EUBI 2024 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 255 https://www.iedea.org/wp-content/plugins/zotpress/

2775998 YAE5EUBI 2023 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 255 https://www.iedea.org/wp-content/plugins/zotpress/

2022

Qian, Y.; Moore, R. D.; Coburn, S. B.; Davy-Mendez, T.; Akgun, K. M. et al. (2022). Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD. J Acquir Immune Defic Syndr, 89 (1), S. 9–18. http://doi.org/10.1097/QAI.0000000000002812.

Kasaie, Parastu; Stewart, Cameron; Humes, Elizabeth; Gerace, Lucas; Zhang, Jinbing et al. (2022). Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States. Annals of Epidemiology, 65, S. 46–55. http://doi.org/10.1016/j.annepidem.2021.08.021.

Lu, H.; Cole, S. R.; Westreich, D.; Hudgens, M. G.; Adimora, A. A. et al. (2022). Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy. AIDS, 36 (2), S. 277–286. http://doi.org/10.1097/QAD.0000000000003069.

Coburn, S. B.; Dionne-Odom, J.; Alcaide, M. L.; Moran, C. A.; Rahangdale, L. et al. (2022). The Association Between HIV Status, Estradiol, and Sex Hormone Binding Globulin Among Premenopausal Women in the Women’s Interagency HIV Study. J Womens Health (Larchmt), 31 (2), S. 183–193. http://doi.org/10.1089/jwh.2021.0276.

Young, J.; Lo Re, V.; Kim, H. N.; Sterling, T. R.; Althoff, K. N. et al. (2022). Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design. Pharmacoepidemiol Drug Saf, 31 (2), S. 214–224. http://doi.org/10.1002/pds.5379.

Althoff, K. N.; Stewart, C. N.; Humes, E.; Zhang, J.; Gerace, L. et al. (2022). The shifting age distribution of people with HIV using antiretroviral therapy in the United States. AIDS, 36 (3), S. 459–471. http://doi.org/10.1097/QAD.0000000000003128.

Koh, M. J.; Merrill, M. H.; Koh, M. J.; Stuver, R.; Alonso, C. D. et al. (2022). Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas. Blood Adv, 6 (5), S. 1420–1431. http://doi.org/10.1182/bloodadvances.2021006208.

Kim, H. N.; Nance, R. M.; Lo Re, V.; Silverberg, M. J.; Franco, R. et al. (2022). Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV. J Acquir Immune Defic Syndr, 89 (4), S. 396–404. http://doi.org/10.1097/QAI.0000000000002886.

McNeil, C. J.; Lee, J. S.; Cole, S. R.; Patel, S. A.; Martin, J. et al. (2022). Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk? AIDS, 36 (5), S. 657–664. http://doi.org/10.1097/QAD.0000000000003151.

Sack, D. E.; Gange, S. J.; Althoff, K. N.; Pettit, A. C.; Kheshti, A. N. et al. (2022). Visualizing the Geography of HIV Observational Cohorts With Density-Adjusted Cartograms. J Acquir Immune Defic Syndr, 89 (5), S. 473–480. http://doi.org/10.1097/QAI.0000000000002903.

Antimycobacterial Susceptibility Testing, Group (2022). Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment. Eur Respir J, 59 (4), S. 2200166. http://doi.org/10.1183/13993003.00166-2022.

Coelho, L. E.; Jenkins, C. A.; Shepherd, B. E.; Pape, J. W.; Mejia Cordero, F. et al. (2022). Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America. Lancet Reg Health Am, 8, S. 100173. http://doi.org/10.1016/j.lana.2021.100173.

Justice, A. C.; Goetz, M. B.; Stewart, C. N.; Hogan, B. C.; Humes, E. et al. (2022). Delayed presentation of HIV among older individuals: a growing problem. Lancet HIV, 9 (4), S. e269–e280. http://doi.org/10.1016/S2352-3018(22)00003-0.

Lesko, C. R.; Hutton, H. E.; Edwards, J. K.; McCaul, M. E.; Fojo, A. T. et al. (2022). Alcohol Use Disorder and Recent Alcohol Use and HIV Viral Non-Suppression Among People Engaged in HIV Care in an Urban Clinic, 2014-2018. AIDS Behav, 26 (4), S. 1299–1307. http://doi.org/10.1007/s10461-021-03487-3.

Coburn, Sally B.; Humes, Elizabeth; Lang, Raynell; Stewart, Cameron; Hogan, Brenna C. et al. (2022). Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States. JAMA Network Open, 5 (6), S. e2215934. http://doi.org/10.1001/jamanetworkopen.2022.15934.

Castilho, J. L.; Bian, A.; Jenkins, C. A.; Shepherd, B. E.; Sigel, K. et al. (2022). CD4/CD8 Ratio and Cancer Risk Among Adults With HIV. J Natl Cancer Inst, 114 (6), S. 854–862. http://doi.org/10.1093/jnci/djac053.

Li, F.; Buchanan, A. L. & Cole, S. R. (2022). Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials. J R Stat Soc Ser C Appl Stat, 71 (3), S. 669–697. http://doi.org/10.1111/rssc.12550.

Park, L. S.; McGinnis, K. A.; Gordon, K. S.; Justice, A. C.; Leyden, W. et al. (2022). SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts. J Acquir Immune Defic Syndr, 90 (3), S. 249–255. http://doi.org/10.1097/QAI.0000000000002943.

Lewis, J. T.; Stephens, J.; Musick, B.; Brown, S.; Malateste, K. et al. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium. J Biomed Inform, 131, S. 104110. http://doi.org/10.1016/j.jbi.2022.104110.

Markowski, M. C.; Pirsl, F.; Keruly, J. C.; Chander, G.; Moore, R. D. et al. (2022). Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience. Prostate Cancer Prostatic Dis. http://doi.org/10.1038/s41391-022-00586-7.

Edwards, J. K.; Cole, S. R.; Breger, T. L.; Filiatreau, L. M.; Zalla, L. et al. (2022). Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population. Clin Infect Dis, 75 (5), S. 867–874. http://doi.org/10.1093/cid/ciab1030.

Lang, R.; Humes, E.; Hogan, B.; Lee, J.; D’Agostino, R. et al. (2022). Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection. J Am Heart Assoc, 11 (19), S. e026473. http://doi.org/10.1161/JAHA.122.026473.

Horberg, M. A.; Watson, E.; Bhatia, M.; Jefferson, C.; Certa, J. M. et al. (2022). Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort. Nat Commun, 13 (1), S. 5822. http://doi.org/10.1038/s41467-022-33573-6.

Bartelt, L. A.; Markmann, A. J.; Nelson, B.; Keys, J.; Root, H. et al. (2022). Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study. MBio, 13 (5), S. e0175122. http://doi.org/10.1128/mbio.01751-22.

Lesko, C. R.; Edwards, J. K.; Hanna, D. B.; Mayor, A. M.; Silverberg, M. J. et al. (2022). Longitudinal HIV care outcomes by gender identity in the United States. AIDS, 36 (13), S. 1841–1849. http://doi.org/10.1097/QAD.0000000000003339.

Lesko, C. R.; Keruly, J. C.; Moore, R. D.; Shen, N. M.; Pytell, J. D. et al. (2022). COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend, 241, S. 109355. http://doi.org/10.1016/j.drugalcdep.2022.109355.

Coburn, S. B.; Lang, R.; Zhang, J.; Palella, F. J.; Horberg, M. A. et al. (2022). Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation. J Acquir Immune Defic Syndr, 91 (5), S. 469–478. http://doi.org/10.1097/QAI.0000000000003083.

Brazier, E.; Ajeh, R.; Maruri, F.; Musick, B.; Freeman, A. et al. (2022). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc, 25 (12), S. e26036. http://doi.org/10.1002/jia2.26036.

Jefferson, C.; Watson, E.; Certa, J. M.; Gordon, K. S.; Park, L. S. et al. (2022). Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort. PLoS One, 17 (11), S. e0276742. http://doi.org/10.1371/journal.pone.0276742.

Zurcher, K.; Cox, S. R.; Ballif, M.; Enane, L. A.; Marcy, O. et al. (2022). Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries. PLOS Glob Public Health, 2 (3), S. e0000180. http://doi.org/10.1371/journal.pgph.0000180.

2021

Sun, Jing; Althoff, Keri N.; Jing, Yuezhou; Horberg, Michael A.; Buchacz, Kate et al. (2021). Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. JAMA Network Open, 4 (2), S. e2037512. http://doi.org/10.1001/jamanetworkopen.2020.37512.

Tsondai, Priscilla Ruvimbo; Davies, Mary-Ann; Singtoroj, Thida; Maxwell, Nicola; McGowan, Catherine C. et al. (2021). Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000003059.

Collins, Lauren F.; Colasanti, Jonathan A.; Nguyen, Minh L.; Moran, Caitlin A.; Lahiri, Cecile D. et al. (2021). The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the United States: applying lessons from high-burden settings. AIDS (London, England), 35 (2), S. 337–341. http://doi.org/10.1097/QAD.0000000000002746.

Markmann, Alena J.; Giallourou, Natasa; Bhowmik, D. Ryan; Hou, Yixuan J.; Lerner, Aaron et al. (2021). Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals. MedRxiv: The Preprint Server for Health Sciences. http://doi.org/10.1101/2021.02.01.21250493.

Nijhawan, Ank E.; Mathews, W. Christopher; Raifman, Julia; Fleming, Julia; Gebo, Kelly A. et al. (2021). Hospitalization rates among persons with HIV who gained Medicaid or private insurance after the Affordable Care Act in 2014. Journal of Acquired Immune Deficiency Syndromes (1999). http://doi.org/10.1097/QAI.0000000000002645.

Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2021). Improved generalized raking estimators to address dependent covariate and failure-time outcome error. Biometrical Journal. Biometrische Zeitschrift. http://doi.org/10.1002/bimj.202000187.

McMahon, Devon E.; Semeere, Aggrey; Laker-Oketta, Miriam; Byakwaga, Helen; Mugglin, Catrina et al. (2021). Global disparities in skin cancer services at HIV treatment centers across 29 countries. The Journal of Investigative Dermatology. http://doi.org/10.1016/j.jid.2021.02.758.

Coburn, Sally B.; Shiels, Meredith S.; Silverberg, Michael J.; Horberg, Michael A.; Gill, M. John et al. (2021). Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America. Journal of Acquired Immune Deficiency Syndromes (1999), 87 (1), S. 663–670. http://doi.org/10.1097/QAI.0000000000002627.

Lesko, Catherine R.; Hutton, Heidi E.; Fojo, Anthony T.; Shen, Nicola M.; Moore, Richard D. et al. (2021). Depression and HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000003005.

Davy-Mendez, Thibaut; Napravnik, Sonia; Eron, Joseph J.; Cole, Stephen R.; Van Duin, David et al. (2021). Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. AIDS (London, England), 35 (8), S. 1229–1239. http://doi.org/10.1097/QAD.0000000000002876.

Davy-Mendez, Thibaut; Napravnik, Sonia; Eron, Joseph J.; Cole, Stephen R.; van Duin, David et al. (2021). Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years. The Journal of Infectious Diseases, 224 (4), S. 657–666. http://doi.org/10.1093/infdis/jiaa786.

Edwards, Jessie K.; Cole, Stephen R.; Breger, Tiffany L.; Rudolph, Jacqueline E.; Filiatreau, Lindsey M. et al. (2021). Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study. Annals of Internal Medicine, 174 (9), S. 1197–1206. http://doi.org/10.7326/M21-0065.

Johnson, Leigh F.; Kariminia, Azar; Trickey, Adam; Yiannoutsos, Constantin T.; Ekouevi, Didier K. et al. (2021). Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. Journal of the International AIDS Society, 24 Suppl 5, S. e25776. http://doi.org/10.1002/jia2.25776.

Lesko, Catherine R.; Hutton, Heidi E.; Edwards, Jessie K.; McCaul, Mary E.; Fojo, Anthony T. et al. (2021). Alcohol Use Disorder and Recent Alcohol Use and HIV Viral Non-Suppression Among People Engaged in HIV Care in an Urban Clinic, 2014-2018. AIDS and Behavior. http://doi.org/10.1007/s10461-021-03487-3.

Amorim, Gustavo; Tao, Ran; Lotspeich, Sarah; Shaw, Pamela A.; Lumley, Thomas et al. (2021). Two-Phase Sampling Designs for Data Validation in Settings with Covariate Measurement Error and Continuous Outcome. Journal of the Royal Statistical Society. Series A, (Statistics in Society), 184 (4), S. 1368–1389. http://doi.org/10.1111/rssa.12689.

McGinnis, Kathleen A.; Skanderson, Melissa; Justice, Amy C.; Akgün, Kathleen M.; Tate, Janet P. et al. (2021). HIV care using differentiated service delivery during the COVID-19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs. Journal of the International AIDS Society, 24 Suppl 6, S. e25810. http://doi.org/10.1002/jia2.25810.

Althoff, Keri N.; Stewart, Cameron N.; Humes, Elizabeth; Zhang, Jinbing; Gerace, Lucas et al. (2021). The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000003128.

Coburn, Sally B.; Humes, Elizabeth; Lang, Raynell; Stewart, Cameron; Hogan, Brenna C. et al. (2021). COVID-19 infections post-vaccination by HIV status in the United States. MedRxiv: The Preprint Server for Health Sciences, S. 2021.12.02.21267182. http://doi.org/10.1101/2021.12.02.21267182.

Sack, Daniel E.; Gange, Stephen J.; Althoff, Keri N.; Pettit, April C.; Kheshti, Asghar N. et al. (2021). Visualizing the geography of HIV observational cohorts with density-adjusted cartograms. Journal of Acquired Immune Deficiency Syndromes (1999). http://doi.org/10.1097/QAI.0000000000002903.

Han, Win Min; Law, Matthew G.; Egger, Matthias; Wools-Kaloustian, Kara; Moore, Richard et al. (2021). Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. The Lancet HIV, 8 (12), S. e766–e775. http://doi.org/10.1016/S2352-3018(21)00265-4.

Kammers, Kai; Chen, Athena; Monaco, Daniel R.; Hudelson, Sarah E.; Grant-McAuley, Wendy et al. (2021). HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression. Frontiers in Immunology, 12, S. 740395. http://doi.org/10.3389/fimmu.2021.740395.

Wohl, David A.; Barzin, Amir H.; Napravnik, Sonia; Davy-Mendez, Thibaut; Smedberg, Jason R. et al. (2021). COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2. PloS One, 16 (12), S. e0260879. http://doi.org/10.1371/journal.pone.0260879.

Zürcher, Kathrin; Reichmuth, Martina L.; Ballif, Marie; Loiseau, Chloé; Borrell, Sonia et al. (2021). Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. The Lancet Microbe, 2 (7), S. e320–e330. http://doi.org/10.1016/S2666-5247(21)00044-6.

2020

IeDEA and COHERE in EuroCoord Cohort Collaboration (2020). All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas. AIDS, 34 (2), S. 277–289. http://doi.org/10.1097/QAD.0000000000002399.

Rohner, Eliane; Bütikofer, Lukas; Schmidlin, Kurt; Sengayi, Mazvita; Maskew, Mhairi et al. (2020). Cervical cancer risk in women living with HIV across four continents: A multicohort study. International Journal of Cancer, 146 (3), S. 601–609. http://doi.org/10.1002/ijc.32260.

Bourgi, Kassem; Jenkins, Cathy A.; Rebeiro, Peter F.; Palella, Frank; Moore, Richard D. et al. (2020). Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. Journal of the International AIDS Society, 23 (4). http://doi.org/10.1002/jia2.25484.

Calkins, Keri L.; Chander, Geetanjali; Joshu, Corinne E.; Visvanathan, Kala; Fojo, Anthony T. et al. (2020). A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEER. Cancer Causes and Control, 31 (5), S. 511–516. http://doi.org/10.1007/s10552-020-01289-x.

Loiseau, Chloé; Brites, Daniela; Reinhard, Miriam; Zürcher, Kathrin; Borrell, Sonia et al. (2020). HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. http://doi.org/10.1128/AAC.00782-20.

Parcesepe, Angela M.; Lancaster, Kathryn; Edelman, E. Jennifer; DeBoni, Raquel; Ross, Jeremy et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS ONE, 15 (8 August), S. e0237772–e0237772. http://doi.org/10.1371/journal.pone.0237772.

Rebeiro, Peter F.; Duda, Stephany N.; Wools-Kaloustian, Kara K.; Nash, Denis & Althoff, Keri N. (2020). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. Journal of the International AIDS Society, 23 (10), S. e25627–e25627. http://doi.org/10.1002/jia2.25627.

Reichmuth, Martina L.; Hömke, Rico; Zürcher, Kathrin; Sander, Peter; Avihingsanon, Anchalee et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial Agents and Chemotherapy, 64 (11). http://doi.org/10.1128/AAC.00513-20.

Kim, H. Nina (2020). Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy. Current Hepatology Reports, 19 (4), S. 345–353. http://doi.org/10.1007/s11901-020-00541-x.

Giganti, Mark J.; Shaw, Pamela A.; Chen, Guanhua; Bebawy, Sally S.; Turner, Megan M. et al. (2020). Accounting for dependent errors in predictors and time-to-event outcomes using electronic health records, validation samples and multiple imputation. Annals of Applied Statistics, 14 (2), S. 1045–1061. http://doi.org/10.1214/20-AOAS1343.

Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2020). Raking and regression calibration: Methods to address bias from correlated covariate and time-to-event error. Statistics in Medicine. http://doi.org/10.1002/sim.8793.

2019

Althoff, Keri N.; Gebo, Kelly A.; Moore, Richard D.; Boyd, Cynthia M.; Justice, Amy C. et al. (2019). Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. The Lancet. HIV, 6 (2), S. e93–e104. http://doi.org/10.1016/S2352-3018(18)30295-9.

Desir, Fidel A.; Lesko, Catherine R.; Moore, Richard D.; Horberg, Michael A.; Wong, Cherise et al. (2019). One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 68 (5), S. 795–802. http://doi.org/10.1093/cid/ciy556.

Bradley, Heather; Althoff, Keri N.; Buchacz, Kate; Brooks, John T.; Gill, M. John et al. (2019). Viral suppression among persons in HIV care in the United States during 2009–2013: sampling bias in Medical Monitoring Project surveillance estimates. Annals of Epidemiology, 31, S. 3–7. http://doi.org/10.1016/j.annepidem.2018.11.005.

Hernández-Ramírez, Raúl U.; Qin, Li; Lin, Haiqun; Leyden, Wendy; Neugebauer, Romain S. et al. (2019). Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study. The Lancet. HIV, 6 (4), S. e240–e249. http://doi.org/10.1016/S2352-3018(18)30360-6.

Poteat, Tonia; Hanna, David B.; Rebeiro, Peter F.; Klein, Marina; Silverberg, Michael J. et al. (2019). Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis. Clinical Infectious Diseases. http://doi.org/10.1093/cid/ciz322.

Althoff, Keri N.; Wong, Cherise; Hogan, Brenna; Desir, Fidel; You, Bin et al. (2019). Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data. Annals of Epidemiology, 33, S. 54–63. http://doi.org/10.1016/j.annepidem.2019.01.015.

Eaton, Ellen F.; Tamhane, Ashutosh; Davy-Mendez, Thibaut; Moore, Richard D.; Mathews, W. Christopher et al. (2019). Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART. Journal of Acquired Immune Deficiency Syndromes (1999), 81 (1), S. e6–e9. http://doi.org/10.1097/QAI.0000000000001999.

Hernández-Ramírez, Raúl U.; Qin, Li; Lin, Haiqun; Leyden, Wendy; Neugebauer, Romain S. et al. (2019). Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada. Clinical Infectious Diseases. http://doi.org/10.1093/cid/ciz329.

Brazier, Ellen; Maruri, Fernanda; Duda, Stephany N.; Tymejczyk, Olga; Wester, C. William et al. (2019). Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. Journal of the International AIDS Society, 22 (7), S. e25331–e25331. http://doi.org/10.1002/jia2.25331.

Justice, Amy C. & Akgün, Kathleen M. (2019). What Does Aging with HIV Mean for Nursing Homes? Journal of the American Geriatrics Society, 67 (7), S. 1327–1329. http://doi.org/10.1111/jgs.15950.

Lo Re, Vincent; Newcomb, Craig W.; Carbonari, Dena M.; Roy, Jason A.; Althoff, Keri N. et al. (2019). Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients. Journal of Acquired Immune Deficiency Syndromes (1999), 82 (1), S. 71–80. http://doi.org/10.1097/QAI.0000000000002094.

Zürcher, Kathrin; Ballif, Marie; Kiertiburanakul, Sasisopin; Chenal, Henri; Yotebieng, Marcel et al. (2019). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. Journal of the International AIDS Society, 22 (9), S. e25392–e25392. http://doi.org/10.1002/jia2.25392.

Johnson, Leigh F.; Anderegg, Nanina; Zaniewski, Elizabeth; Eaton, Jeffrey W.; Rebeiro, Peter F. et al. (2019). Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration. AIDS (London, England), 33 Suppl 3, S. S283–S294. http://doi.org/10.1097/QAD.0000000000002358.

Miles, D. R. Bailey; Bilal, Usama; Hutton, Heidi E.; Lau, Bryan; Lesko, Catherine R. et al. (2019). Tobacco Smoking, Substance Use, and Mental Health Symptoms in People with HIV in an Urban HIV Clinic. Journal of Health Care for the Poor and Underserved, 30 (3), S. 1083–1102. http://doi.org/10.1353/hpu.2019.0075.

2018

IeDEA and COHERE Cohort Collaborations (2018). Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/cix915.

Altekruse, Sean F.; Shiels, Meredith S.; Modur, Sharada P.; Land, Stephanie R.; Crothers, Kristina A. et al. (2018). Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS (London, England), 32 (4), S. 513–521. http://doi.org/10.1097/QAD.0000000000001721.

Bengtson, Angela M.; Pence, Brian W.; Eaton, Ellen F.; Edwards, Jessie K.; Eron, Joseph J. et al. (2018). Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antiviral Therapy. http://doi.org/10.3851/IMP3223.

Elion, Richard A.; Althoff, Keri N.; Zhang, Jinbing; Moore, Richard D.; Gange, Stephen J. et al. (2018). Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001642.

Haas, Andreas D.; Zaniewski, Elizabeth; Anderegg, Nanina; Ford, Nathan; Fox, Matthew P. et al. (2018). Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. Journal of the International AIDS Society, 21 (2), S. e25084–e25084. http://doi.org/10.1002/jia2.25084.

Lesko, Catherine R.; Jacobson, Lisa P.; Althoff, Keri N.; Abraham, Alison G.; Gange, Stephen J. et al. (2018). Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities. International Journal of Epidemiology. http://doi.org/10.1093/ije/dyx283.

Parcesepe, Angela M.; Mugglin, Catrina; Nalugoda, Fred; Bernard, Charlotte; Yunihastuti, Evy et al. (2018). Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium. Journal of the International AIDS Society, 21 (3), S. e25101–e25101. http://doi.org/10.1002/jia2.25101.

Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin; Wools-Kaloustian, Kara; Althoff, Keri et al. (2018). HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Medicine, 15 (3), S. e1002534–e1002534. http://doi.org/10.1371/journal.pmed.1002534.

Wong, Cherise; Gange, Stephen J.; Moore, Richard D.; Justice, Amy C.; Buchacz, Kate et al. (2018). Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 66 (8), S. 1230–1238. http://doi.org/10.1093/cid/cix998.

Giles, Michelle L.; Achhra, Amit C.; Abraham, Alison G.; Haas, Andreas D.; Gill, Michael John et al. (2018). Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Journal of the International AIDS Society, 21 (6), S. e25149–e25149. http://doi.org/10.1002/jia2.25149.

Lee, Jennifer S.; Cole, Stephen R.; Achenbach, Chad J.; Dittmer, Dirk P.; Richardson, David B. et al. (2018). Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy. PloS One, 13 (6), S. e0197665–e0197665. http://doi.org/10.1371/journal.pone.0197665.

Yanik, Elizabeth L.; Hernández-Ramírez, Raúl U.; Qin, Li; Lin, Haiqun; Leyden, Wendy et al. (2018). Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. JAIDS Journal of Acquired Immune Deficiency Syndromes, 78 (5), S. 499–504. http://doi.org/10.1097/QAI.0000000000001719.

Burger, Emily A.; Dyer, Michael A.; Sy, Stephen; Palefsky, Joel M.; de Pokomandy, Alexandra et al. (2018). Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. Journal of Acquired Immune Deficiency Syndromes (1999), 79 (1), S. 10–19. http://doi.org/10.1097/QAI.0000000000001727.

Grover, Surbhi; Desir, Fidel; Jing, Yuezhou; Bhatia, Rohini K.; Trifiletti, Daniel M. et al. (2018). Reduced cancer survival among adults with HIV and an AIDS-defining illnesses despite no difference in cancer stage at diagnosis. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001842.

Rohner, Eliane & AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018). Non-Hodgkin lymphoma risk in adults living with HIV across five continents: a multicohort study. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000002003.

Buchanan, Ashley L.; Hudgens, Michael G.; Cole, Stephen R.; Mollan, Katie R.; Sax, Paul E. et al. (2018). Generalizing evidence from randomized trials using inverse probability of sampling weights. Journal of the Royal Statistical Society: Series A (Statistics in Society), 181 (4), S. 1193–1209. http://doi.org/10.1111/rssa.12357.

Card, Kiffer G.; Lachowsky, Nathan J.; Althoff, Keri N.; Schafer, Katherine; Hogg, Robert S. et al. (2018). A systematic review of the geospatial barriers to antiretroviral initiation, adherence and viral suppression among people living with HIV. Sexual Health, 16 (1), S. 1–1. http://doi.org/10.1071/SH18104.

Eyawo, Oghenowede; McGinnis, Kathleen A.; Justice, Amy C.; Fiellin, David A.; Hahn, Judith A. et al. (2018). Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected. Journal of Acquired Immune Deficiency Syndromes (1999), 77 (2), S. 135–143. http://doi.org/10.1097/QAI.0000000000001588.

Parcesepe, Angela M.; Bernard, Charlotte; Agler, Robert; Ross, Jeremy; Yotebieng, Marcel et al. (2018). Mental health and HIV: research priorities related to the implementation and scale up of “treat all” in sub-Saharan Africa. Journal of Virus Eradication, 4 (Suppl 2), S. 16–25. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/30515310

Zaniewski, Elizabeth; Tymejczyk, Olga; Kariminia, Azar; Desmonde, Sophie; Leroy, Valériane et al. (2018). IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development. Journal of Virus Eradication, 4 (Suppl 2), S. 9–15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/30515309

Raifman, Julia; Althoff, Keri; Rebeiro, Peter F.; Cheever, Laura W.; Hauck, Heather et al. (2018). HIV viral suppression after transition from having no healthcare coverage and relying on Ryan White HIV/AIDS Program Support to Medicaid or private health insurance. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciy1088.

2017

Fritz, Cristin Q.; Blevins, Meridith; Lindegren, Mary Lou; Wools-Kaloutsian, Kara; Musick, Beverly S. et al. (2017). Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. Journal of the International AIDS Society, 20 (1), S. 1–14. http://doi.org/10.7448/IAS.20.1.20933.

Rebeiro, Peter F.; Abraham, Alison G.; Horberg, Michael A.; Althoff, Keri N.; Yehia, Baligh R. et al. (2017). Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada. AIDS Patient Care and STDs, 31 (3), S. 129–144. http://doi.org/10.1089/apc.2016.0178.

Anderegg, Nanina; Johnson, Leigh F.; Zaniewski, Elizabeth; Althoff, Keri N.; Balestre, Eric et al. (2017). All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS (London, England), 31 Suppl 1, S. S31–S40. http://doi.org/10.1097/QAD.0000000000001321.

Dubrow, Robert; Qin, Li; Lin, Haiqun; Hernández-Ramírez, Raúl U.; Neugebauer, Romain S. et al. (2017). Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001394.

Lesko, Catherine R.; Tong, Weiqun; Moore, Richard D. & Lau, Bryan (2017). Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort. AIDS and Behavior, 21 (4), S. 1016–1024. http://doi.org/10.1007/s10461-016-1585-5.

Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2017). Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX. Statistics in Medicine, 37 (8), S. 1276–1289. http://doi.org/10.1002/sim.7554.

Canan, C. E.; Lau, B.; McCaul, M. E.; Keruly, J.; Moore, R. D. et al. (2017). Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individuals. HIV Medicine, 18 (5), S. 332–341. http://doi.org/10.1111/hiv.12433.

Drozd, Daniel R.; Kitahata, Mari M.; Althoff, Keri N.; Zhang, Jinbing; Gange, Stephen J. et al. (2017). Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001450.

Jiamsakul, Awachana; Kariminia, Azar; Althoff, Keri N.; Cesar, Carina; Cortes, Claudia P. et al. (2017). HIV viral load suppression in adults and children receiving antiretroviral therapy – results from the IeDEA collaboration. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001499.

Muzaale, A. D.; Althoff, K. N.; Sperati, C. J.; Abraham, A. G.; Kucirka, L. M. et al. (2017). Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 17 (7), S. 1823–1832. http://doi.org/10.1111/ajt.14235.

Engels, Eric A.; Yanik, Elizabeth L.; Wheeler, Willian; Gill, M. John; Shiels, Meredith S. et al. (2017). Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 65 (4), S. 636–643. http://doi.org/10.1093/cid/cix392.

Gonsalves, Gregg S.; Paltiel, A. David; Cleary, Paul D.; Gill, Michael J.; Kitahata, Mari M. et al. (2017). A Flow-Based Model of the HIV Care Continuum in the United States. Journal of Acquired Immune Deficiency Syndromes (1999), 75 (5), S. 548–553. http://doi.org/10.1097/QAI.0000000000001429.

AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord & AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord (2017). Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 65 (8), S. 1316–1326. http://doi.org/10.1093/cid/cix480.

Falade-Nwulia, Oluwaseun; Sutcliffe, Catherine; Moon, Juhi; Chander, Geetanjali; Wansom, Tanyaporn et al. (2017). High hepatitis C cure rates among black and nonblack human immunodeficiency virus-infected adults in an urban center. Hepatology (Baltimore, Md.), 66 (5), S. 1402–1412. http://doi.org/10.1002/hep.29308.

Raifman, Julia R.; Gebo, Kelly A.; Mathews, William Christopher; Korthuis, Philip Todd; Ghanem, Khalil G. et al. (2017). Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004-2014. Journal of Acquired Immune Deficiency Syndromes (1999), 76 (4), S. 409–416. http://doi.org/10.1097/QAI.0000000000001514.

Shiels, Meredith S.; Althoff, Keri N.; Pfeiffer, Ruth M.; Achenbach, Chad J.; Abraham, Alison G. et al. (2017). HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 64 (4), S. 468–475. http://doi.org/10.1093/cid/ciw764.

Wong, Cherise; Gange, Stephen J.; Buchacz, Kate; Moore, Richard D.; Justice, Amy C. et al. (2017). First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 64 (4), S. 459–467. http://doi.org/10.1093/cid/ciw804.

2016

Koethe, John R.; Jenkins, Cathy A.; Lau, Bryan; Shepherd, Bryan E.; Justice, Amy C. et al. (2016). Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Research and Human Retroviruses, 32 (1), S. 50–58. http://doi.org/10.1089/aid.2015.0147.

Lesko, Catherine R. & Todd, Jonathan V. (2016). The Best of Both Worlds: Collaborations Can Improve Epidemiological Analyses of Public Health Data. Sexually Transmitted Diseases, 43 (1), S. 41–43. http://doi.org/10.1097/OLQ.0000000000000396.

Rebeiro, Peter F.; Gange, Stephen J.; Horberg, Michael A.; Abraham, Alison G.; Napravnik, Sonia et al. (2016). Geographic Variations in Retention in Care among HIV-Infected Adults in the United States. PloS One, 11 (1), S. e0146119–e0146119. http://doi.org/10.1371/journal.pone.0146119.

Cesar, Carina; Koethe, John R.; Giganti, Mark J.; Rebeiro, Peter; Althoff, Keri N. et al. (2016). Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. Journal of the International AIDS Society, 19 (1). http://doi.org/10.7448/IAS.19.1.20684.

Garner, Will; White, Kirsten; Szwarcberg, Javier; McCallister, Scott; Zhong, Lijie et al. (2016). Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 62 (7), S. 929–934. http://doi.org/10.1093/cid/civ1034.

Geng, Elvin H.; Odeny, Thomas A.; Lyamuya, Rita; Nakiwogga-Muwanga, Alice; Diero, Lameck et al. (2016). Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 62 (7), S. 935–944. http://doi.org/10.1093/cid/civ1004.

Lesko, Catherine R.; Moore, Richard D.; Tong, Weiqun & Lau, Bryan (2016). Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014. AIDS (London, England), 30 (9), S. 1447–1455. http://doi.org/10.1097/QAD.0000000000001087.

Park, Lesley S.; Tate, Janet P.; Sigel, Keith; Rimland, David; Crothers, Kristina et al. (2016). Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. AIDS (London, England), 30 (11), S. 1795–1806. http://doi.org/10.1097/QAD.0000000000001112.

Pettit, April C.; Mendes, Adell; Jenkins, Cathy; Napravnik, Sonia; Freeman, Aimee et al. (2016). Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment. Journal of Acquired Immune Deficiency Syndromes (1999), 72 (5), S. 572–578. http://doi.org/10.1097/QAI.0000000000001018.

Buchacz, Kate; Lau, Bryan; Jing, Yuezhou; Bosch, Ronald; Abraham, Alison G. et al. (2016). Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. Journal of Infectious Diseases, 214 (6), S. 862–872. http://doi.org/10.1093/infdis/jiw085.

Lesko, Catherine R.; Edwards, Jessie K.; Moore, Richard D. & Lau, Bryan (2016). A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU. AIDS (London, England), 30 (14), S. 2227–2234. http://doi.org/10.1097/QAD.0000000000001183.

Koethe, John R.; Jenkins, Cathy A.; Lau, Bryan; Shepherd, Bryan E.; Wester, William et al. (2016). Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. Journal of Acquired Immune Deficiency Syndromes (1999), 73 (2), S. 197–204. http://doi.org/10.1097/QAI.0000000000001035.

Rachlis, Beth; Karwa, Rakhi; Chema, Celia; Pastakia, Sonak; Olsson, Sten et al. (2016). Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Safety, 39 (10), S. 959–976. http://doi.org/10.1007/s40264-016-0434-9.

Klein, Marina B.; Althoff, Keri N.; Jing, Yuezhou; Lau, Bryan; Kitahata, Mari et al. (2016). Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 63 (9), S. 1160–1167. http://doi.org/10.1093/cid/ciw531.

Schrack, Jennifer A.; Jacobson, Lisa P.; Althoff, Keri N.; Erlandson, Kristine M.; Jamieson, Beth D. et al. (2016). Effect of HIV-infection and cumulative viral load on age-related decline in grip strength. AIDS (London, England), 30 (17), S. 2645–2652. http://doi.org/10.1097/QAD.0000000000001245.

Althoff, Keri N. (2016). The Shifting Paradigm of Care for Adults Living With HIV: Smoking Cessation for Longer Life. The Journal of Infectious Diseases, 214 (11), S. 1618–1620. http://doi.org/10.1093/infdis/jiw434.

Althoff, Keri N.; Rebeiro, Peter F.; Hanna, David B.; Padgett, Denis; Horberg, Michael A. et al. (2016). A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. Journal of the International AIDS Society, 19 (1), S. 20707–20707. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27049052

Mayor, Angel M.; Santiago-Rodriguez, Eduardo J.; Rios-Olivares, Eddy; Tortolero-Luna, Guillermo & Hunter-Mellado, Robert F. (2016). Malignancies Trends in a Hispanic Cohort of HIV Persons in Puerto Rico before and after cART. International Journal of Cancer Research, 12 (2), S. 92–100. http://doi.org/10.3923/ijcr.2016.92.100.

2015

Geng, Elvin H.; Neilands, Torsten B.; Thièbaut, Rodolphe; Bwana, Mwebesa Bosco; Nash, Denis et al. (2015). CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. International Journal of Epidemiology, 44 (1), S. 251–263. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25859596

Abraham, Alison G.; Althoff, Keri N.; Jing, Yuezhou; Estrella, Michelle M.; Kitahata, Mari M. et al. (2015). End-stage renal disease among HIV-infected adults in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 60 (6), S. 941–949. http://doi.org/10.1093/cid/ciu919.

Geng, Elvin H.; Odeny, Thomas A.; Lyamuya, Rita E.; Nakiwogga-Muwanga, Alice; Diero, Lameck et al. (2015). Estimation of Mortality among HIV-infected people on antiretroviral therapy treatment in east Africa: a sampling based approach in an observational, multisite, cohort study. The Lancet. HIV, 2 (3), S. e107–e116. http://doi.org/10.1016/S2352-3018(15)00002-8.

Crowell, Trevor A.; Berry, Stephen A.; Fleishman, John A.; LaRue, Richard W.; Korthuis, Philip T. et al. (2015). Impact of hepatitis coinfection on healthcare utilization among persons living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999), 68 (4), S. 425–431. http://doi.org/10.1097/QAI.0000000000000490.

King, Joseph T.; Perkal, Melissa F.; Rosenthal, Ronnie A.; Gordon, Adam J.; Crystal, Stephen et al. (2015). Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators. JAMA Surgery, 150 (4), S. 343–351. http://doi.org/10.1001/jamasurg.2014.2257.

Yehia, Baligh R.; Rebeiro, Peter; Althoff, Keri N.; Agwu, Allison L.; Horberg, Michael A. et al. (2015). Impact of age on retention in care and viral suppression. Journal of Acquired Immune Deficiency Syndromes (1999), 68 (4), S. 413–419. http://doi.org/10.1097/QAI.0000000000000489.

Lesko, Catherine R.; Cole, Stephen R.; Miller, William C.; Westreich, Daniel; Eron, Joseph J. et al. (2015). Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 60 (11), S. 1700–1707. http://doi.org/10.1093/cid/civ183.

Butt, A. A.; Yan, P.; Shaikh, O. S.; Freiberg, M. S.; Lo Re, V. et al. (2015). Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings. Journal of Viral Hepatitis, 22 (9), S. 691–700. http://doi.org/10.1111/jvh.12375.

Poteat, Tonia C.; Hanna, David B. & Althoff, Keri N. (2015). Short communication: feasibility and acceptability of developing a multisite clinical cohort of transgender people with HIV infection. AIDS Research and Human Retroviruses, 31 (9), S. 870–872. http://doi.org/10.1089/aid.2015.0055.

Edwards, Jessie K.; Cole, Stephen R.; Westreich, Daniel; Mugavero, Michael J.; Eron, Joseph J. et al. (2015). Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (7), S. 1189–1195. http://doi.org/10.1093/cid/civ463.

Koethe, J. R.; Jenkins, C. A.; Lau, B.; Shepherd, B. E.; Silverberg, M. J. et al. (2015). Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010. HIV Medicine, 16 (9), S. 572–577. http://doi.org/10.1111/hiv.12259.

Silverberg, Michael J.; Lau, Bryan; Achenbach, Chad J.; Jing, Yuezhou; Althoff, Keri N. et al. (2015). Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Annals of Internal Medicine, 163 (7), S. 507–518. http://doi.org/10.7326/M14-2768.

Berry, Stephen A.; Ghanem, Khalil G.; Mathews, William Christopher; Korthuis, Philip Todd; Yehia, Baligh R. et al. (2015). Brief Report: Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States. Journal of Acquired Immune Deficiency Syndromes (1999), 70 (3), S. 275–279. http://doi.org/10.1097/QAI.0000000000000711.

Rebeiro, Peter F.; Althoff, Keri N.; Lau, Bryan; Gill, John; Abraham, Alison G. et al. (2015). Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. American Journal of Epidemiology, 182 (11), S. 952–960. http://doi.org/10.1093/aje/kwv181.

Santiago-Rodríguez, Eduardo J.; Mayor, Angel M.; Fernández-Santos, Diana M. & Hunter-Mellado, Robert F. (2015). Profile of HIV-Infected Hispanics with Pancytopenia. International Journal of Environmental Research and Public Health, 13 (1), S. ijerph13010038–ijerph13010038. http://doi.org/10.3390/ijerph13010038.

Kitahata, Mari M.; Drozd, Daniel R.; Crane, Heidi M.; Van Rompaey, Stephen E.; Althoff, Keri N. et al. (2015). Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design. AIDS Research and Treatment, 2015, S. 923194–923194. http://doi.org/10.1155/2015/923194.

Lai, Hong; Stitzer, Maxine; Treisman, Glenn; Moore, Richard; Brinker, Jeffrey et al. (2015). Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study. Journal of Addiction Medicine, 9 (4), S. 331–339. http://doi.org/10.1097/ADM.0000000000000140.

2014

IeDEA and ART Cohort Collaborations, Matthias; Avila, Dorita; Althoff, Keri N.; Mugglin, Catrina; Wools-Kaloustian, Kara et al. (2014). Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. Journal of Acquired Immune Deficiency Syndromes (1999), 65 (1), S. e8-16. http://doi.org/10.1097/QAI.0b013e3182a39979.

Anderson, Jeffrey P.; Tchetgen Tchetgen, Eric J.; Lo Re, Vincent; Tate, Janet P.; Williams, Paige L. et al. (2014). Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 58 (5), S. 719–727. http://doi.org/10.1093/cid/cit779.

Konerman, Monica A.; Mehta, Shruti H.; Sutcliffe, Catherine G.; Vu, Trang; Higgins, Yvonne et al. (2014). Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs. Hepatology (Baltimore, Md.), 59 (3), S. 767–775. http://doi.org/10.1002/hep.26741.

Althoff, Keri N.; Rebeiro, Peter; Brooks, John T.; Buchacz, Kate; Gebo, Kelly et al. (2014). Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 58 (8), S. 1185–1189. http://doi.org/10.1093/cid/ciu044.

Crane, H. M.; Heckbert, S. R.; Drozd, D. R.; Budoff, M. J.; Delaney, J. A. C. et al. (2014). Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. American Journal of Epidemiology, 179 (8), S. 996–1005. http://doi.org/10.1093/aje/kwu010.

Vogler, Mary A.; Smeaton, Laura M.; Wright, Rodney L.; Cardoso, Sandra W.; Sanchez, Jorge et al. (2014). Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227. Journal of Acquired Immune Deficiency Syndromes (1999), 65 (5), S. 542–550. http://doi.org/10.1097/QAI.0000000000000072.

Yanik, Elizabeth L.; Napravnik, Sonia; Cole, Stephen R.; Achenbach, Chad J.; Gopal, Satish et al. (2014). Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence. AIDS (London, England), 28 (7), S. 979–987. http://doi.org/10.1097/QAD.0000000000000167.

Kim, H. Nina; Rodriguez, Carla V.; Van Rompaey, Stephen; Eron, Joseph J.; Thio, Chloe L. et al. (2014). Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort. Journal of Acquired Immune Deficiency Syndromes (1999), 66 (1), S. 96–101. http://doi.org/10.1097/QAI.0000000000000126.

Achenbach, Chad J.; Buchanan, Ashley L.; Cole, Stephen R.; Hou, Lifang; Mugavero, Michael J. et al. (2014). HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 58 (11), S. 1599–1606. http://doi.org/10.1093/cid/ciu076.

Hulbert, Alicia; Hooker, Craig M.; Keruly, Jeanne C.; Brown, Travis; Horton, Karen et al. (2014). Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 9 (6), S. 752–759. http://doi.org/10.1097/JTO.0000000000000161.

Gopal, Satish; Patel, Monita R.; Achenbach, Chad J.; Yanik, Elizabeth L.; Cole, Stephen R. et al. (2014). Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 59 (2), S. 279–286. http://doi.org/10.1093/cid/ciu270.

Park, Lesley S.; Tate, Janet P.; Rodriguez-Barradas, Maria C.; Rimland, David; Goetz, Matthew Bidwell et al. (2014). Cancer Incidence in HIV-Infected Versus Uninfected Veterans: Comparison of Cancer Registry and ICD-9 Code Diagnoses. Journal of AIDS & Clinical Research, 5 (7), S. 1000318–1000318. http://doi.org/10.4172/2155-6113.1000318.

Santiago-Rodríguez, Eduardo J.; Mayor, Angel M.; Fernández-Santos, Diana M.; Ruiz-Candelaria, Yelitza & Hunter-Mellado, Robert F. (2014). Anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Research Notes, 7 (1), S. 439–439. http://doi.org/10.1186/1756-0500-7-439.

Wong, Cherise; Althoff, Keri & Gange, Stephen J. (2014). Identifying the appropriate comparison group for HIV-infected individuals. Current Opinion in HIV and AIDS, 9 (4), S. 379–385. http://doi.org/10.1097/COH.0000000000000063.

Yehia, Baligh R.; Herati, Ramin S.; Fleishman, John A.; Gallant, Joel E.; Agwu, Allison L. et al. (2014). Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts. PloS One, 9 (7), S. e102766–e102766. http://doi.org/10.1371/journal.pone.0102766.

Haines, Charles F.; Fleishman, John A.; Yehia, Baligh R.; Berry, Stephen A.; Moore, Richard D. et al. (2014). Increase in CD4 count among new enrollees in HIV care in the modern antiretroviral therapy era. Journal of Acquired Immune Deficiency Syndromes (1999), 67 (1), S. 84–90. http://doi.org/10.1097/QAI.0000000000000228.

Mugavero, Michael J.; Westfall, Andrew O.; Cole, Stephen R.; Geng, Elvin H.; Crane, Heidi M. et al. (2014). Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 59 (10), S. 1471–1479. http://doi.org/10.1093/cid/ciu603.

Rebeiro, Peter F.; Horberg, Michael A.; Gange, Stephen J.; Gebo, Kelly A.; Yehia, Baligh R. et al. (2014). Strong agreement of nationally recommended retention measures from the Institute of Medicine and Department of Health and Human Services. PloS One, 9 (11), S. e111772–e111772. http://doi.org/10.1371/journal.pone.0111772.

Beachler, Daniel C.; Abraham, Alison G.; Silverberg, Michael J.; Jing, Yuezhou; Fakhry, Carole et al. (2014). Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. Oral Oncology, 50 (12), S. 1169–1176. http://doi.org/10.1016/j.oraloncology.2014.09.011.

Buchanan, Ashley L.; Hudgens, Michael G.; Cole, Stephen R.; Lau, Bryan & Adimora, Adaora A. (2014). Worth the Weight: Using Inverse Probability Weighted Cox Models in AIDS Research. AIDS Research and Human Retroviruses, 30 (12), S. 1170–1177. http://doi.org/10.1089/aid.2014.0037.

Duda, Stephany N.; Farr, Amanda M.; Lindegren, Mary Lou; Blevins, Meridith; Wester, C. William et al. (2014). Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaborati. Journal of the International AIDS Society, 17 (1), S. 19045–19045. http://doi.org/10.7448/IAS.17.1.19045.

2013

Justice, Amy C.; Modur, Sharada P.; Tate, Janet P.; Althoff, Keri N.; Jacobson, Lisa P. et al. (2013). Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. Journal of Acquired Immune Deficiency Syndromes (1999), 62 (2), S. 149–163. http://doi.org/10.1097/QAI.0b013e31827df36c.

Napravnik, Sonia; Eron, Joseph J.; Sterling, Timothy R.; Juday, Timothy; Uy, Jonathan et al. (2013). Outcomes of Second Combination Antiretroviral Therapy Regimens Among HIV-Infected Persons in Clinical Care: A Multicenter Cohort Study. AIDS Research and Human Retroviruses, 29 (3), S. 574–580. http://doi.org/10.1089/AID.2012.0210.

Rebeiro, Peter; Althoff, Keri N.; Buchacz, Kate; Gill, John; Horberg, Michael et al. (2013). Retention among North American HIV-infected persons in clinical care, 2000-2008. Journal of Acquired Immune Deficiency Syndromes (1999), 62 (3), S. 356–362. http://doi.org/10.1097/QAI.0b013e31827f578a.

Abraham, Alison G.; D’Souza, Gypsyamber; Jing, Yuezhou; Gange, Stephen J.; Sterling, Timothy R. et al. (2013). Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. Journal of Acquired Immune Deficiency Syndromes (1999), 62 (4), S. 405–413. http://doi.org/10.1097/QAI.0b013e31828177d7.

Hanna, David B.; Buchacz, Kate; Gebo, Kelly A.; Hessol, Nancy A.; Horberg, Michael A. et al. (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 56 (8), S. 1174–1182. http://doi.org/10.1093/cid/cit003.

Taiwo, Babafemi; Yanik, Elizabeth L.; Napravnik, Sonia; Ryscavage, Patrick; Koletar, Susan L. et al. (2013). Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy. AIDS (London, England), 27 (10), S. 1593–1602. http://doi.org/10.1097/QAD.0b013e3283601115.

Yanik, Elizabeth L.; Napravnik, Sonia; Ryscavage, Patrick; Eron, Joseph J.; Koletar, Susan L. et al. (2013). Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010. Journal of Acquired Immune Deficiency Syndromes (1999), 63 (2), S. 216–220. http://doi.org/10.1097/QAI.0b013e31828d69f1.

Flickinger, Tabor E.; Saha, Somnath; Moore, Richard D. & Beach, Mary C. (2013). Higher quality communication and relationships are associated with improved patient engagement in HIV care. Journal of Acquired Immune Deficiency Syndromes (1999), 63 (3), S. 362–366. http://doi.org/10.1097/QAI.0b013e318295b86a.

Abraham, Alison G.; Strickler, Howard D. & D’Souza, Gypsyamber (2013). Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening. Journal of Acquired Immune Deficiency Syndromes (1999), 63 (5), S. e163–e163. http://doi.org/10.1097/QAI.0b013e31829cb7c3.

Jonassaint, Charles R.; Haywood, Carlton; Korthuis, Philip Todd; Cooper, Lisa A.; Saha, Somnath et al. (2013). The impact of depressive symptoms on patient-provider communication in HIV care. AIDS Care, 25 (9), S. 1185–1192. http://doi.org/10.1080/09540121.2012.752788.

Lucas, Gregory M.; Jing, Yuezhou; Sulkowski, Mark; Abraham, Alison G.; Estrella, Michelle M. et al. (2013). Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. The Journal of Infectious Diseases, 208 (8), S. 1240–1249. http://doi.org/10.1093/infdis/jit373.

Haines, Charles F.; Moore, Richard D.; Bartlett, John G.; Sears, Cynthia L.; Cosgrove, Sara E. et al. (2013). Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS (London, England), 27 (17), S. 2799–2807. http://doi.org/10.1097/01.aids.0000432450.37863.e9.

Hanna, David B.; Buchacz, Kate; Gebo, Kelly A.; Hessol, Nancy A.; Horberg, Michael A. et al. (2013). Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PloS One, 8 (11), S. e78952–e78952. http://doi.org/10.1371/journal.pone.0078952.

Samji, Hasina; Cescon, Angela; Hogg, Robert S.; Modur, Sharada P.; Althoff, Keri N. et al. (2013). Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PloS One, 8 (12), S. e81355–e81355. http://doi.org/10.1371/journal.pone.0081355.

El-Maouche, Diala; Mehta, Shruti H.; Sutcliffe, Catherine G.; Higgins, Yvonne; Torbenson, Michael S. et al. (2013). Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antiviral Therapy, 18 (2), S. 237–242. http://doi.org/10.3851/IMP2264.

2012

Hanna, David B.; Selik, Richard M.; Tang, Tian & Gange, Stephen J. (2012). Disparities among US states in HIV-related mortality in persons with HIV infection, 2001-2007. AIDS (London, England), 26 (1), S. 95–103. http://doi.org/10.1097/QAD.0b013e32834dcf87.

Chander, Geetanjali; Stanton, Cassandra; Hutton, Heidi E.; Abrams, David B.; Pearson, Jennifer et al. (2012). Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS and Behavior, 16 (2), S. 383–388. http://doi.org/10.1007/s10461-011-9914-1.

Kiragga, Agnes N.; Castelnuovo, Barbara; Kamya, Moses R.; Moore, Richard & Manabe, Yukari C. (2012). Regional differences in predictive accuracy of WHO immunologic failure criteria. AIDS (London, England), 26 (6), S. 768–770. http://doi.org/10.1097/QAD.0b013e32835143e3.

Berry, Stephen A.; Fleishman, John A.; Moore, Richard D.; Gebo, Kelly A. & HIV Research Network (2012). Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008. Journal of Acquired Immune Deficiency Syndromes (1999), 59 (4), S. 368–375. http://doi.org/10.1097/QAI.0b013e318246b862.

Silverberg, Michael J.; Lau, Bryan; Justice, Amy C.; Engels, Eric; Gill, M. John et al. (2012). Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 54 (7), S. 1026–1034. http://doi.org/10.1093/cid/cir1012.

Yehia, Baligh R.; Fleishman, John A.; Metlay, Joshua P.; Korthuis, P. Todd; Agwu, Allison L. et al. (2012). Comparing different measures of retention in outpatient HIV care. AIDS (London, England), 26 (9), S. 1131–1139. http://doi.org/10.1097/QAD.0b013e3283528afa.

Fleishman, John A.; Yehia, Baligh R.; Moore, Richard D.; Korthuis, P. Todd; Gebo, Kelly A. et al. (2012). Establishment, retention, and loss to follow-up in outpatient HIV care. Journal of Acquired Immune Deficiency Syndromes (1999), 60 (3), S. 249–259. http://doi.org/10.1097/QAI.0b013e318258c696.

Limketkai, Berkeley N.; Mehta, Shruti H.; Sutcliffe, Catherine G.; Higgins, Yvonne M.; Torbenson, Michael S. et al. (2012). Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA, 308 (4), S. 370–378. http://doi.org/10.1001/jama.2012.7844.

Yehia, Baligh R.; Fleishman, John A.; Metlay, Joshua P.; Moore, Richard D. & Gebo, Kelly A. (2012). Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA, 308 (4), S. 339–342. http://doi.org/10.1001/jama.2012.5927.

Yehia, Baligh R.; Mehta, Jimish M.; Ciuffetelli, Danielle; Moore, Richard D.; Pham, Paul A. et al. (2012). Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 55 (4), S. 593–599. http://doi.org/10.1093/cid/cis491.

Althoff, Keri N.; Buchacz, Kate; Hall, H. Irene; Zhang, Jinbing; Hanna, David B. et al. (2012). U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Annals of Internal Medicine, 157 (5), S. 325–335. http://doi.org/10.7326/0003-4819-157-5-201209040-00005.

Kalayjian, Robert C.; Lau, Bryan; Mechekano, Rhoderick N.; Crane, Heidi M.; Rodriguez, Benigno et al. (2012). Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS (London, England), 26 (15), S. 1907–1915. http://doi.org/10.1097/QAD.0b013e328357f5ed.

Moore, Richard D.; Keruly, Jeanne C. & Bartlett, John G. (2012). Improvement in the health of HIV-infected persons in care: reducing disparities. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 55 (9), S. 1242–1251. http://doi.org/10.1093/cid/cis654.

Kowalski, Stefan; Colantuoni, Elizabeth; Lau, Bryan; Keruly, Jeanne; McCaul, Mary E. et al. (2012). Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999), 61 (4), S. 455–461. http://doi.org/10.1097/QAI.0b013e3182712d39.

2011

Moore, R. D. (2011). Epidemiology of HIV Infection in the United States: Implications for Linkage to Care. Clinical Infectious Diseases, 52 (Supplement 2), S. S208–S213. http://doi.org/10.1093/cid/ciq044.

Lau, Bryan; Cole, Stephen R. & Gange, Stephen J. (2011). Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry. Statistics in Medicine, 30 (6), S. 654–665. http://doi.org/10.1002/sim.4123.

Woreta, Tinsay A.; Sutcliffe, Catherine G.; Mehta, Shruti H.; Brown, Todd T.; Higgins, Yvonne et al. (2011). Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology, 140 (3), S. 809–817. http://doi.org/10.1053/j.gastro.2010.11.052.

McGowan, Catherine C.; Weinstein, David D.; Samenow, Charles P.; Stinnette, Samuel E.; Barkanic, Gema et al. (2011). Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PloS One, 6 (4), S. e18462–e18462. http://doi.org/10.1371/journal.pone.0018462.

Korthuis, P. Todd; Saha, Somnath; Chander, Geetanjali; McCarty, Dennis; Moore, Richard D. et al. (2011). Substance use and the quality of patient-provider communication in HIV clinics. AIDS and Behavior, 15 (4), S. 832–841. http://doi.org/10.1007/s10461-010-9779-8.

Moore, Richard D.; Bartlett, John G. & Gallant, Joel E. (2011). Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients. PloS One, 6 (7), S. e21843–e21843. http://doi.org/10.1371/journal.pone.0021843.

Abraham, Alison G.; Lau, Bryan; Deeks, Steven; Moore, Richard D.; Zhang, Jinbing et al. (2011). Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. American Journal of Epidemiology, 174 (6), S. 727–735. http://doi.org/10.1093/aje/kwr141.

Agwu, Allison L.; Fleishman, John A.; Korthuis, P. Todd; Siberry, George K.; Ellen, Jonathan M. et al. (2011). Disparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research Network. Journal of Acquired Immune Deficiency Syndromes (1999), 58 (1), S. 100–107. http://doi.org/10.1097/QAI.0b013e31822327df.

Sterling, Timothy R.; Lau, Bryan; Zhang, Jinbing; Freeman, Aimee; Bosch, Ronald J. et al. (2011). Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. The Journal of Infectious Diseases, 204 (6), S. 893–901. http://doi.org/10.1093/infdis/jir421.

Berry, Stephen A.; Ghanem, Khalil G.; Page, Kathleen R.; Gange, Stephen J.; Thio, Chloe L. et al. (2011). Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999-2007. Sexually Transmitted Infections, 87 (6), S. 469–475. http://doi.org/10.1136/sextrans-2011-050051.

Hoffmann, Christopher J.; Fielding, Katherine L.; Johnston, Victoria; Charalambous, Salome; Innes, Craig et al. (2011). Changing predictors of mortality over time from cART start: implications for care. Journal of Acquired Immune Deficiency Syndromes (1999), 58 (3), S. 269–276. http://doi.org/10.1097/QAI.0b013e31823219d1.

Mugavero, Michael J.; Napravnik, Sonia; Cole, Stephen R.; Eron, Joseph J.; Lau, Bryan et al. (2011). Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 53 (9), S. 927–935. http://doi.org/10.1093/cid/cir526.

Monroe, Anne K.; Chander, Geetanjali & Moore, Richard D. (2011). Control of medical comorbidities in individuals with HIV. Journal of Acquired Immune Deficiency Syndromes (1999), 58 (5), S. 458–462. http://doi.org/10.1097/QAI.0b013e31823801c4.

Park, Lesley S.; Tate, Janet P.; Justice, Amy C.; Lo Re, Vincent; Lim, Joseph K. et al. (2011). FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 20 (12), S. 2512–2517. http://doi.org/10.1158/1055-9965.EPI-11-0582.

2010

Brown, Todd T.; Mehta, Shruti H.; Sutcliffe, Catherine; Higgins, Yvonne; Torbenson, Michael S. et al. (2010). Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons. AIDS (London, England), 24 (6), S. 811–817. http://doi.org/10.1097/QAD.0b013e3283333651.

Berry, S. A.; Manabe, Y. C.; Moore, R. D. & Gebo, K. A. (2010). Hospitalization risk following initiation of highly active antiretroviral therapy. HIV Medicine, 11 (5), S. 289–298. http://doi.org/10.1111/j.1468-1293.2009.00776.x.

Engels, Eric A.; Pfeiffer, Ruth M.; Landgren, Ola & Moore, Richard D. (2010). Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. Journal of Acquired Immune Deficiency Syndromes (1999), 54 (1), S. 78–84. http://doi.org/10.1097/01.qai.0000371677.48743.8d.

Althoff, Keri N.; Gange, Stephen J.; Klein, Marina B.; Brooks, John T.; Hogg, Robert S. et al. (2010). Late presentation for human immunodeficiency virus care in the United States and Canada. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 50 (11), S. 1512–1520. http://doi.org/10.1086/652650.

Lau, Bryan; Chander, Geetanjali; Gange, Stephen J. & Moore, Richard D. (2010). Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study. AIDS Research and Therapy, 7 (1), S. 25–25. http://doi.org/10.1186/1742-6405-7-25.

Althoff, Keri N.; Justice, Amy C.; Gange, Stephen J.; Deeks, Steven G.; Saag, Michael S. et al. (2010). Virologic and immunologic response to HAART, by age and regimen class. AIDS (London, England), 24 (16), S. 2469–2479. http://doi.org/10.1097/QAD.0b013e32833e6d14.

Berry, Stephen A.; Ghanem, Khalil G.; Page, Kathleen R.; Thio, Chloe L.; Moore, Richard D. et al. (2010). Gonorrhoea and chlamydia testing rates of HIV-infected men: low despite guidelines. Sexually Transmitted Infections, 86 (6), S. 481–484. http://doi.org/10.1136/sti.2009.041541.

Gebo, Kelly A.; Fleishman, John A.; Conviser, Richard; Hellinger, James; Hellinger, Fred J. et al. (2010). Contemporary costs of HIV healthcare in the HAART era. AIDS (London, England), 24 (17), S. 2705–2715. http://doi.org/10.1097/QAD.0b013e32833f3c14.

Shiels, Meredith S.; Goedert, James J.; Moore, Richard D.; Platz, Elizabeth A. & Engels, Eric A. (2010). Reduced risk of prostate cancer in U.S. Men with AIDS. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 19 (11), S. 2910–2915. http://doi.org/10.1158/1055-9965.EPI-10-0741.

Althoff, Keri N.; Gebo, Kelly A.; Gange, Stephen J.; Klein, Marina B.; Brooks, John T. et al. (2010). CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Research and Therapy, 7 (1), S. 45–45. http://doi.org/10.1186/1742-6405-7-45.

Fleishman, John A.; Yehia, Baligh R.; Moore, Richard D.; Gebo, Kelly A. & HIV Research Network (2010). The economic burden of late entry into medical care for patients with HIV infection. Medical Care, 48 (12), S. 1071–1079. http://doi.org/10.1097/MLR.0b013e3181f81c4a.

Heaton, R. K.; Clifford, D. B.; Franklin, D. R.; Woods, S. P.; Ake, C. et al. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75 (23), S. 2087–2096. http://doi.org/10.1212/WNL.0b013e318200d727.

Jain, Vivek & Deeks, Steven G. (2010). When to Start Antiretroviral Therapy FV. Topics in HIV Medicine : A Publication of the International AIDS Society, USA, 18 (April), S. 60–68. http://doi.org/10.1007/s11904-010-0044-6.

2009

Kirk, Gregory D.; Astemborski, Jacquie; Mehta, Shruti H.; Spoler, Chuck; Fisher, Cedric et al. (2009). Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 48 (7), S. 963–972. http://doi.org/10.1086/597350.

Kitahata, Mari M.; Gange, Stephen J.; Abraham, Alison G.; Merriman, Barry; Saag, Michael S. et al. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. The New England Journal of Medicine, 360 (18), S. 1815–1826. http://doi.org/10.1056/NEJMoa0807252.

Chander, Geetanjali; Himelhoch, Seth; Fleishman, John A.; Hellinger, James; Gaist, Paul et al. (2009). HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care, 21 (5), S. 655–663. http://doi.org/10.1080/09540120802459762.

Lau, Bryan; Cole, Stephen R. & Gange, Stephen J. (2009). Competing risk regression models for epidemiologic data. American Journal of Epidemiology, 170 (2), S. 244–256. http://doi.org/10.1093/aje/kwp107.

Gallant, Joel E. & Moore, Richard D. (2009). Renal function with use of a tenofovir-containing initial antiretroviral regimen. AIDS (London, England), 23 (15), S. 1971–1975. http://doi.org/10.1097/QAD.0b013e32832c96e9.

Lau, Bryan; Gange, Stephen J.; Kirk, Gregory D. & Moore, Richard D. (2009). Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies. Epidemiology (Cambridge, Mass.), 20 (5), S. 664–672. http://doi.org/10.1097/EDE.0b013e3181a71519.

Grinsztejn, Beatriz; Veloso, Valdilea G.; Friedman, Ruth K.; Moreira, Ronaldo I.; Luz, Paula M. et al. (2009). Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS (London, England), 23 (16), S. 2107–2114. http://doi.org/10.1097/QAD.0b013e32832ec494.

Deeks, Steven G.; Gange, Stephen J.; Kitahata, Mari M.; Saag, Michael S.; Justice, Amy C. et al. (2009). Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 49 (10), S. 1582–1590. http://doi.org/10.1086/644768.

Losina, Elena; Schackman, Bruce R.; Sadownik, Sara N.; Gebo, Kelly A.; Walensky, Rochelle P. et al. (2009). Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 49 (10), S. 1570–1578. http://doi.org/10.1086/644772.

Silverberg, Michael J.; Chao, Chun; Leyden, Wendy A.; Xu, Lanfang; Tang, Beth et al. (2009). HIV infection and the risk of cancers with and without a known infectious cause. AIDS (London, England), 23 (17), S. 2337–2345. http://doi.org/10.1097/QAD.0b013e3283319184.

2008

Long, Jessica L.; Engels, Eric A.; Moore, Richard D. & Gebo, Kelly A. (2008). Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS (London, England), 22 (4), S. 489–496. http://doi.org/10.1097/QAD.0b013e3282f47082.

Lucas, Gregory M.; Lau, Bryan; Atta, Mohamed G.; Fine, Derek M.; Keruly, Jeanne et al. (2008). Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. The Journal of Infectious Diseases, 197 (11), S. 1548–1557. http://doi.org/10.1086/587994.

Lau, Bryan; Cole, Stephen R.; Moore, Richard D. & Gange, Stephen J. (2008). Evaluating competing adverse and beneficial outcomes using a mixture model. Statistics in Medicine, 27 (21), S. 4313–4327. http://doi.org/10.1002/sim.3293.

Moore, Richard D.; Gebo, Kelly A.; Lucas, Gregory M. & Keruly, Jeanne C. (2008). Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 47 (8), S. 1102–1104. http://doi.org/10.1086/592115.

2007

Gange, Stephen J.; Kitahata, Mari M.; Saag, Michael S.; Bangsberg, David R.; Bosch, Ronald J. et al. (2007). Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). International Journal of Epidemiology, 36 (2), S. 294–301. http://doi.org/10.1093/ije/dyl286.

Lau, Bryan; Gange, Stephen J. & Moore, Richard D. (2007). Interval and clinical cohort studies: epidemiological issues. AIDS Research and Human Retroviruses, 23 (6), S. 769–776. http://doi.org/10.1089/aid.2006.0171.

NA-ACCORD

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Global Newsletter – January

Global Newsletter – November

Global Newsletter – September

Global Newsletter – July

Global Newsletter – April